Enroflon — Tablets for Intrauterine Use in Cattle and Pigs, 32 Tablets

Enroflon is an antibacterial veterinary medicine with a foaming base, intended for the prevention and treatment of uterine inflammatory conditions in cattle and pigs.

Composition.
Active ingredient: enrofloxacin, 0.36 g per tablet.

Pharmacological Action.
Enrofloxacin has a broad spectrum of antibacterial activity and inhibits the growth and development of Gram-positive and Gram-negative microorganisms, as well as Mycoplasma species.

The foaming base helps distribute the medicine evenly across the uterine mucosa. The carbon dioxide released supports penetration of the active ingredient into deeper layers of the endometrium.

Indications.

Administration and Dosage.
For prevention, administer one tablet once, immediately after expulsion of the fetal membranes, abortion, or assistance with complicated or abnormal parturition.

For treatment, administer 1–2 tablets at 24-hour intervals, for 2–3 administrations, until clinical recovery.

The tablets are inserted through the cervix into the uterine cavity using a hand protected by a disposable polyethylene glove or an appropriate instrument.

Side Effects.
No side effects are reported when used at the recommended doses.

Contraindications.
None specified.

Special Instructions and Withdrawal Periods.
Milk obtained from cows during treatment and for 72 hours after the last administration may be used to feed animals only after boiling.

Slaughter for meat and the use of milk for human consumption are permitted 72 hours after the last administration. Meat from animals slaughtered before the end of this period should be used to feed carnivorous animals or for meat-and-bone meal production.

Storage.
Store in a dry, dark place at a temperature not exceeding 25°C. Shelf life: 3 years.

Packaging: 32 tablets.